63 studies on Copper peptide class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
The discovery of this potent synergy between GHK-Cu and hyaluronic acid represents a significant advancement in anti-aging technology, offering a novel and highly effective strategy for enhancing skin health. By demon…
This research provides a valuable, non-toxic method for significantly enhancing laccase production using GHK-Cu as an inducer, addressing safety concerns associated with traditional inducers. The use of a GHK-chelated…
This research presents a highly selective and efficient fluorescent sensor for Cu(II) ions, which holds significant implications for the biotech and peptide community. The ability to accurately and selectively detect …
This study provides compelling evidence that GHK-Cu holds significant promise as a novel therapeutic agent for Alzheimer's disease. Its ability to simultaneously improve cognitive function, reduce amyloid pathology, a…
This research represents a pivotal advancement in peptide delivery technology, effectively overcoming the significant challenges of peptide instability and poor bioavailability under harsh conditions. The development …
This research highlights GHK's potential as a powerful cytoprotective compound against metal-induced damage, which is a significant contributing factor in neurodegenerative diseases. Its multifaceted ability to preven…
This research provides compelling evidence that GHK-Cu could serve as a novel and effective therapeutic agent for silicosis, a disease with a high incidence and no current specific treatment options. By targeting PRDX…
This research highlights the significant potential of GHK-Cu-loaded hydroxyapatite microspheres as a dual-action injectable filler. The sustained release of GHK-Cu combined with the structural support of HA offers a p…
If successful, this Phase 2 study could provide crucial evidence supporting GHK-Cu Gel as a novel and effective treatment to accelerate acute skin wound healing. This could significantly improve patient outcomes by re…